Vaishali Pharma

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue8.2719.8622.2825.4110.18
Expenses7.1017.7519.9024.688.07
EBITDA1.172.112.380.732.11
EBIT1.072.012.280.582.02
Profit Before Tax1.081.872.140.632.01
Net Profit0.811.401.610.201.51
Financial Ratios
Operating Profit Margin14.15%10.62%10.73%2.87%20.73%
Net Profit Margin9.79%7.05%7.23%0.79%14.83%
Earning Per Share (Diluted)0.771.331.520.191.43
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.4.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI